KaryoCreate: A CRISPR-based technology to study chromosome-specific aneuploidy by targeting human centromeres
Nazario Bosco(Institute for Systems Biology), Teresa Davoli(NYU Langone Health)
Cited by 69
Related Papers
Proteogenomic insights suggest druggable pathways in endometrial carcinoma
|Cancer Cell|2023|53
Interferon Epsilon Loss Is Elusive 9p21 Link to Immune-Cold Tumors, Resistant to Immune Checkpoint Therapy, and Endogenous CXCL9/10 Induction
|Journal of Thoracic Oncology|2024|12